C8 Health vs PERISCOPE

PERISCOPE rests on a 2025 Lancet Regional Health Europe paper covering 253,010 procedures at three hospitals in the Netherlands and Belgium, with 23,903 infections within 30 days and 30-day AUROC of 0.82, 0.82 and 0.91 on temporal validation. The design was retrospective and two authors work at Healthplus.ai. The vendor states CE marking as a Class IIa device under EU MDR, plus ISO 13485 and ISO 27001, and makes no FDA claim. openFDA lists no Healthplus.ai record, and funding news describes FDA clearance as a goal. The vendor says implementation typically takes 8 to 12 weeks, depending on the EHR. Its buyer is a hospital surgical department that wants 7-day and 30-day postoperative infection risk from EHR data.

C8 Health is a protocol platform and a different purchase, sold to health systems. Its proof library covers surgical site infection and shows glucose compliance at UTMB moving from about 72% to over 81%, a testimonial the vendor curates. MetroHealth, Lahey and UTMB Health are named customers.